SCHEMBL4650047

SCHEMBL4650047

O=c1cc(-c2ccc(O)cc2O)oc2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 7/20 1.00
▸ CYP3A4 P08684 5/20 1.00
▸ KDM4E B2RXH2 4/20 1.00
▸ MEN1 O00255 3/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ CYP2C19 P33261 3/20 1.00
▸ CYP2C9 P11712 2/20 1.00
▸ AKR1C3 P42330 1/20 0.77
▸ AKR1C2 P52895 1/20 0.77
▸ AKR1C1 Q04828 1/20 0.77
▸ SMN1; SMN2 Q16637 5/20 0.71
▸ ALOX15 P16050 3/20 0.71
▸ TP53 P04637 3/20 0.71
▸ TNKS O95271 4/20 0.68
▸ NPC1 O15118 4/20 0.68
▸ RAB9A P51151 4/20 0.68
▸ TDP1 Q9NUW8 2/20 0.68
▸ BCHE P06276 1/20 0.68
▸ POLB P06746 1/20 0.68
▸ ACHE P22303 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16670860 0.89 HPGD (0.81) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL29370223 0.89 HPGD (0.81) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL312255 0.87 AKR1C3 (1.00) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL6832163 0.87 HPGD (0.80) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL311588 0.87 HPGD (0.76) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL311714 0.87 HPGD (0.76) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL30933461 0.86 HPGD (0.75) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL21704894 0.85 HPGD (0.74) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL15676335 0.85 HPGD (0.74) HPGDCYP3A4KDM4EMEN1KMT2A
SCHEMBL7121068 0.84 HPGD (0.72) HPGDCYP3A4KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 — — US claimed
JP-2003504327-A — — 2003-02-04 — — JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 — — EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 — — WO claimed
EP-2999467-B1 USE OF A COMBINATION OF TWO COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF BONE DISORDERS INST NAT DE LA RECH AGRONOMIQUE INRA (FR) 2020-01-08 — — EP disclosed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 — — EP disclosed
EP-2999467-A1 USE OF A COMBINATION OF TWO COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF BONE DISORDERS Institut National De La Recherche Agronomique (INRA) (FR) 2016-03-30 — — EP disclosed
WO-2014184484-A1 USE OF A COMBINATION OF TWO COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF BONE DISORDERS INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE - INRA (FR) 2014-11-20 — — WO disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 — — US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 — — EP disclosed
WO-2012096494-A9 AGENT CONTAINING B-RING-SUBSTITUTED FLAVONOID DERIVATIVES FOR TREATING ARTHRITIS 강원대학교 산학협력단 (KR) 2013-01-24 — — WO disclosed
WO-2012096494-A2 AGENT CONTAINING B-RING-SUBSTITUTED FLAVONOID DERIVATIVES FOR TREATING ARTHRITIS 강원대학교 산학협력단 (KR) 2012-07-19 — — WO disclosed
WO-2007115181-A2 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-10-11 — — WO disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 — — US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 — — EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 — — WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 — — US disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 — — US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 — — EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP HPGD 558/4885CYP3A4 3010/4885KDM4E 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback